Stay updated with breaking news from Cv Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CV Sciences, Inc. (OTCMKTS:CVSI – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 36,100 shares, a growth of 132.9% from the April 15th total of 15,500 shares. Based on an average daily volume of 274,300 shares, the […]
CV Sciences, Inc. (OTCMKTS:CVSI – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 36,100 shares, a growth of 132.9% from the April 15th total of 15,500 shares. Based on an average trading volume of 274,300 shares, the short-interest ratio is currently 0.1 days. […]
/PRNewswire/ -- The CBD oil market is set to grow by USD 5,361.32 million from 2022 to 2027 progressing at a CAGR of 27.63% during the forecast period. The...
Should You Buy or Sell CV Sciences Stock? Get The Latest CVSI Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.
A Nevada federal judge has thrown out a suit from the co-founder of CBD company CV Sciences Inc. that alleged an investor failed to follow through on a profit-sharing agreement, saying the court doesn't have any jurisdiction over the Virginia-based investor.